Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis
- 15 March 2007
- journal article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 66 (9), 1202-1209
- https://doi.org/10.1136/ard.2006.067504
Abstract
To investigate the role of reactive oxygen species (ROS) in the development of the various patterns of systemic sclerosis (SSc) and the mechanisms of ROS production by endothelial cells and fibroblasts. Production of hydrogen peroxide (H(2)O(2)), nitric oxide (NO) and cellular proliferation were determined following incubation of endothelial cells and fibroblasts with 56 SSc and 30 healthy sera. Correlations were established between those markers, the type and the severity of the clinical involvements, and the response to treatment. The factors leading to ROS production were determined. H(2)O(2) production by endothelial cells and fibroblasts was higher after incubation with SSc sera than with normal sera (p<0.001) and with sera from SSc patients with severe complications than sera from other patients (p<0.05). Sera from patients with lung fibrosis triggered the proliferation of fibroblasts more than other SSc sera (p<0.001), whereas sera from patients with vascular complications exerted no proliferative effect on fibroblasts, but inhibited endothelial cell growth (p<0.05) and induced NO overproduction (p<0.05). Bosentan reduced NO release by 32%, whereas N-acetylcystein potentiated 5-fluorouracil (5FU) to inhibit fibroblast proliferation by 78%. Those serum-mediated effects did not involve antibodies but advanced oxidation protein products that selectively triggered cells to produce H(2)O(2) or NO. SSc sera induce the production of different types of ROS that selectively activate endothelial cells or fibroblasts, leading to vascular or fibrotic complications. Assaying serum-induced ROS production allows clinical activity of the disease to be followed and appropriate treatments to be selected.This publication has 40 references indexed in Scilit:
- Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertensionEuropean Respiratory Journal, 2006
- Criteria for the classification of early systemic sclerosis.2001
- Exhaled Nitric Oxide Is Elevated in Patients With Progressive Systemic Sclerosis Without Interstitial Lung DiseaseSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2001
- The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis.2001
- Systemic sclerosis: environmental and occupational risk factorsCurrent Opinion in Rheumatology, 2000
- Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cellsNature Medicine, 2000
- Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis: Findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1Arthritis & Rheumatism, 2000
- Abnormalities of erythrocyte membrane fluidity, lipid composition, and lipid peroxidation in systemic sclerosis: Evidence of free radical–mediated injuryArthritis & Rheumatism, 2000
- Systemic sclerosis (scleroderma) and related disorders: clinical aspectsBest Practice & Research Clinical Rheumatology, 2000
- Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skinThe Journal of Pathology, 1999